The estimated Net Worth of Jon Carl Serbousek is at least $6.04 Milion dollars as of 18 November 2021. Mr. Serbousek owns over 1,670 units of Orthofix Medical Inc stock worth over $1,962,929 and over the last 5 years he sold OFIX stock worth over $0. In addition, he makes $4,076,200 as President, Chief Executive Officer a Director at Orthofix Medical Inc.
Jon has made over 2 trades of the Orthofix Medical Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 1,670 units of OFIX stock worth $52,004 on 18 November 2021.
The largest trade he's ever made was buying 2,900 units of Orthofix Medical Inc stock on 27 February 2020 worth over $102,892. On average, Jon trades about 241 units every 33 days since 2019. As of 18 November 2021 he still owns at least 112,812 units of Orthofix Medical Inc stock.
You can see the complete history of Mr. Serbousek stock trades at the bottom of the page.
Jon Carl Serbousek is President, Chief Executive Officer, Director of the Company. Mr. Serbousek joined the company in August 2019 as President of Global Spine. He has over 30 years’ experience in the medical device and biotech industries serving in several leadership positions at Biomet Inc., including Worldwide President of Biomet Biologics, Worldwide Group President of Orthopedics, and President of U.S. Orthopedics. Prior to joining Biomet, Mr. Serbousek held various positions within Medtronic Inc. including Worldwide Division President, Spine, Worldwide Vice President and General Manager of Biologics for their Spine and Biologics business. Additionally, he spent 13 years with DePuy Orthopedics, a Johnson & Johnson company where he served in numerous roles of increasing responsibility, including the Vice President of Marketing and Product Development and as Vice President of Spinal Operations. In addition, Mr. Serbousek has held numerous board positions at for profit and not-for-profit organizations. He earned his Bachelor of Science degree in Engineering from Washington State University, his Masters of Science degree in Bioengineering from the University of Utah and completed several advanced management programs including a program at the IMD International School of Management in Lausanne, Switzerland.
As the President, Chief Executive Officer a Director of Orthofix Medical Inc, the total compensation of Jon Serbousek at Orthofix Medical Inc is $4,076,200. There are no executives at Orthofix Medical Inc getting paid more.
Jon Serbousek is 59, he's been the President, Chief Executive Officer a Director of Orthofix Medical Inc since 2019. There are 6 older and 11 younger executives at Orthofix Medical Inc. The oldest executive at Orthofix Medical Inc is Ronald Matricaria, 77, who is the Independent Chairman of the Board.
Jon's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.
Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth a Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
Orthofix Medical Inc executives and other stock owners filed with the SEC include: